Not applicableStudy completedNCT03011242What this trial is testingDC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsAWho this might be right forPsoriatic Arthritis University of Rochester 47
Testing effectiveness (Phase 2)Looking for participantsNCT07265596What this trial is testingEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)Who this might be right forProdromal Parkinsons Disease Michael J. Fox Foundation for Parkinson's Research 100
Not applicableLooking for participantsNCT06222138What this trial is testingStudy of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Institut Claudius Regaud 80
Early research (Phase 1)Study completedNCT02097875What this trial is testingSafety Study of a Fluorescent Marker to Visualize Cancer CellsWho this might be right forSkin Neoplasms Blaze Bioscience Australia Pty Ltd 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04245865What this trial is testingTocotrienol and Bevacizumab in Metastatic Colorectal CancerWho this might be right forColorectal Cancer Metastatic Vejle Hospital 83
Very early researchStudy completedNCT01268020What this trial is testingEvaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HCWho this might be right forAlzheimer Disease Institute for Neurodegenerative Disorders 5
Not applicableStudy completedNCT00690664What this trial is testingEvaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian HairWho this might be right forScalp Health Wake Forest University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05312398What this trial is testingCAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment RegimenWho this might be right forMetastatic Colorectal Adenocarcinoma University of Campania Luigi Vanvitelli 219
Not applicableUnknownNCT03240198What this trial is testingBiological Markers for Professional COPDWho this might be right forCopd Centre Hospitalier Intercommunal Creteil 400
Not applicableUnknownNCT01951781What this trial is testingNeutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm NewbornsWho this might be right forNosocomial Infection University Hospital, Montpellier 153
Early research (Phase 1)Study completedNCT01461109What this trial is testingResearch Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy ControlsWho this might be right forParkinson DiseaseAlzheimer Disease Institute for Neurodegenerative Disorders 4
Large-scale testing (Phase 3)Looking for participantsNCT06081244What this trial is testingNeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)Who this might be right forTriple Negative Breast Cancer Women's Cancer Study Group GmbH 348
Not applicableStudy completedNCT01036516What this trial is testingPET Assays of Striatal Dopamine Marker in Cocaine CravingWho this might be right forNeural SystemsDrug AbuseCocaine Dependence National Institute on Drug Abuse (NIDA) 14
Not applicableStudy completedNCT00109018What this trial is testingBiomarkers for Cardiovascular DiseaseWho this might be right forCoronary Artery Disease National Heart, Lung, and Blood Institute (NHLBI) 120
Not applicableUnknownNCT04877223What this trial is testingMonocytes as Predictors of Cystic Fibrosis-related Bone DiseaseWho this might be right forCystic Fibrosis Université de Reims Champagne-Ardenne 80
Not applicableStudy completedNCT04468113What this trial is testingClip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant TherapyWho this might be right forPrimary Breast Cancer Kliniken Essen-Mitte 339
Post-approval studies (Phase 4)Study completedNCT05889468What this trial is testingPostpartum ASA and NT-proBNPWho this might be right forBlood Pressure Duke University 114
Not applicableStudy completedNCT00407329What this trial is testingUrokinase Plasminogen Activator System in Benign Prostatic HyperplasiaWho this might be right forBPH Queen's University 30
Not applicableLooking for participantsNCT03893929What this trial is testingThe Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese PopulationWho this might be right forProstate Cancer Chinese University of Hong Kong 5,000
Not applicableStudy completedNCT00899548What this trial is testingDNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast CancerWho this might be right forBreast Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 182